Clinical Trials in Chicago

Showing 5361-5380 of 20,493 trials

Oxygenation in Vascular Lesions of the Colon

NCT06230731

The goal of this clinical trial is to evaluate oxygenation in the colon in people with acquired vascular abnormalities in the proximal colon.

Vascular Lesion

University of Chicago30 participantsStarted Feb 2024

Chicago, Illinois, United States

Active Not RecruitingPhase 12.2 miles

Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors

NCT02608385

Phase I to determine safety of combining stereotactic body radiotherapy (SBRT) with pembrolizumab in patients with advanced solid tumors. The study will determine safe doses of radiation by organ site when used together with pembrolizumab. The study will also provide the opportunity to evaluate changes in the tumor caused by SBRT. The study will include 2 expansion cohorts: * Partially Irradiated Large Volume Tumors Cohort: Patients with at least one lesion greater than 65cc amenable to SBRT followed by pembrolizumab. * Oligometastatic Cohort: Patients with limited metastatic disease (4 or fewer lesions)

Solid Tumor

University of Chicago117 participantsStarted Dec 2015

Chicago, Illinois, United States

No Longer Available2.2 miles

Medical Access Program for Patritumab Deruxtecan

NCT06099639

The purpose of this Medical Access Program is to provide access to HER3-DXd for eligible patients with NSCLC who, in their treating physician's opinion, have an unmet clinical need which cannot be treated with approved and commercially available drugs and who cannot enter a clinical trial prior to commercial availability.

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer

Daiichi Sankyo

Springdale, Arkansas, United States • Los Angeles, California, United States • Aurora, Colorado, United States +18 more locations

Oxygenation in Vascular Lesions of the Colon

Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors

Medical Access Program for Patritumab Deruxtecan

Find Trials by Condition in Chicago

Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

TAC T-cells for the Treatment of HER2-positive Solid Tumors

Accupressure of P6 to Reduce Nausea During Cesarean Section

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

Electrical Nerve Block for Amputation Pain

Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

ProVIDE II Bridging Study

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Promoting Shared Decision Making for Severe Aortic Stenosis

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections